Pharma · Private company
Janssen R&D Ireland
Track this companyFree. Adds Janssen R&D Ireland to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Boosted Protease Inhibitor (bPI)Phase 3 · Human Immunodeficiency Virus Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- D/C/F/TAFPhase 3 · Human Immunodeficiency Virus Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- FTC/TDFPhase 3 · Human Immunodeficiency Virus Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- RilpivirinePhase 3 · HIV-1 InfectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected ParticipantsPHASE3 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02269917 · fetched Nov 12, 2026
- A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1PHASE3 · COMPLETED · started Feb 1, 2011ClinicalTrials.gov NCT01266902 · fetched Nov 12, 2026